Celltrion | 068270 - 现金及等价物

金融业

KRW

KRW 768.81B

现金及等价物

KRW 56.79B

KRW 92.83B

KRW 481.57B

KRW 292.71B

KRW 160.58B

股息收益率

0.38

KRW 13.41B

KRW 19.64B

1.07K

EPS每股收益

KRW 1.35K

股本和储备

KRW 434.82B

KRW 39.29B

债务利息支出

KRW 19B

KRW 779.01M

KRW 411.27B

KRW 38255.69B

KRW 8.82B

KRW 119.22B

KRW 12.9B

普通股股本

KRW 229.65M

58.97

KRW 11.84B

KRW 1240B

销售和管理费用

KRW 9.32B

KRW 126B

贸易债权人

KRW 88.58B

应收帐款人

KRW 2009.82B

	现金及等价物	更改		日
Akebia Therapeutics	USD 155.55M		7.1M	2026-06
Alaunos Therapeutics	USD 354K		1.03M	2026-03
Avita Medical	AUD 10.24M		1.98M	2025-12
Celltrion	KRW 56.79B		6.92B	2026-03
Dianthus Therapeutics	USD 110.55M		517.12M	2026-06
Ionis Pharmaceuticals	USD 350.06M		1.57B	2026-06
IQVIA Holdings	USD 1.91B		38M	2026-06
Moderna	USD 1.72B		185M	2026-06
Organon & Co	USD 1.13B		16M	2026-06
Revvity	USD 1.02B		162.62M	2026-06
Tectonic Therapeutic	USD 236.89M		16.9M	2026-03
Viatris	USD 886.5M		917.7M	2026-06
Xeris Pharmaceuticals	USD 121.75M		10M	2026-06